Mesoblast Limited (MESO)
NASDAQ: MESO · IEX Real-Time Price · USD
6.45
-0.33 (-4.87%)
At close: Jul 2, 2024, 4:00 PM
6.55
+0.10 (1.55%)
After-hours: Jul 2, 2024, 5:05 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $736.10 million as of July 2, 2024. Its market cap has increased by 23.98% in one year.
Market Cap
736.10M
Enterprise Value
780.54M
1-Year Change
23.98%
Ranking
Category
Stock Price
$6.45
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $736.10M, an increase of 24.09%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 688.00M | 284.14% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 785.17M |
| Nuvation Bio | 781.06M |
| 89bio | 763.46M |
| Perspective Therapeutics | 755.22M |
| GeneDx Holdings | 750.27M |
| CureVac | 746.94M |
| Harrow Health | 744.79M |
| Cytek Biosciences | 736.44M |